Mapping malaria by combining parasite genomic and epidemiologic data.

BMC Med
Authors
Keywords
Abstract

BACKGROUND: Recent global progress in scaling up malaria control interventions has revived the goal of complete elimination in many countries. Decreasing transmission intensity generally leads to increasingly patchy spatial patterns of malaria transmission in elimination settings, with control programs having to accurately identify remaining foci in order to efficiently target interventions.

FINDINGS: The role of connectivity between different pockets of local transmission is of increasing importance as programs near elimination since humans are able to transfer parasites beyond the limits of mosquito dispersal, thus re-introducing parasites to previously malaria-free regions. Here, we discuss recent advances in the quantification of spatial epidemiology of malaria, particularly Plasmodium falciparum, in the context of transmission reduction interventions. Further, we highlight the challenges and promising directions for the development of integrated mapping, modeling, and genomic approaches that leverage disparate datasets to measure both connectivity and transmission.

CONCLUSION: A more comprehensive understanding of the spatial transmission of malaria can be gained using a combination of parasite genetics and epidemiological modeling and mapping. However, additional molecular and quantitative methods are necessary to answer these public health-related questions.

Year of Publication
2018
Journal
BMC Med
Volume
16
Issue
1
Pages
190
Date Published
2018 Oct 18
ISSN
1741-7015
DOI
10.1186/s12916-018-1181-9
PubMed ID
30333020
PubMed Central ID
PMC6193293
Links
Grant list
DP2 LM013102 / LM / NLM NIH HHS / United States
U54GM088558 / NH / NIH HHS / United States
R35 GM124715 / GM / NIGMS NIH HHS / United States
U54 GM088558 / GM / NIGMS NIH HHS / United States
Wellcome Trust / United Kingdom
106866/Z/15/Z / WT_ / Wellcome Trust / United Kingdom
R35GM124715 / NH / NIH HHS / United States
MR/R015600/1 / MRC_ / Medical Research Council / United Kingdom
MR/N01507X/1 / MRC_ / Medical Research Council / United Kingdom